Braegen-03

N/A

Report date: 2025/10/15 15:52:40
NMEFirst In Class

Base Information

Drug NameBraegen-03
Drug Alias NameBraegen-03
ClassificationSmall molecules
Mechanisms of ActionLegumain inhibitors
TargetsLegumain
Therapy Area/IndicationsAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesShenzhen Braegen Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Braegen Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A